Core Capability 3

DeSci & IP-NFTs

Alternative Funding Models for Biotech Innovation

Traditional biotech funding models face significant challenges including lengthy timelines, high dilution, and limited access to capital. Our approach explores decentralized science (DeSci) and intellectual property NFTs as alternative funding mechanisms based on blockchain technology, transparency, and community participation.

Biotech Funding Challenges

Many promising research projects struggle to secure adequate funding for development. The transition from research concept to clinical candidate often faces significant funding gaps, limiting innovation in biotechnology.

Blockchain-Based IP Management

We explore blockchain technology to create transparent, verifiable records of therapeutic intellectual property. Our approach treats novel therapeutic designs as valuable digital assets that can be tokenized, making IP more accessible and liquid for funding purposes.

Key Capabilities Deployed

  • Computational Drug Design: AI-powered platform for generating novel therapeutic candidates.
  • Blockchain IP Registry: Distributed ledger system for recording and verifying intellectual property.

Tactical Breakdown

Our operational approach is a multi-stage process designed for maximum impact. Each step builds upon the last, creating a cascade of strategic advantage.

1

Therapeutic Generation

2

IP Documentation

3

Asset Tokenization

4

Community Funding

Target Audience & Value Proposition

DeSci Communities & Bio-DAOs

We provide a steady stream of high-quality, AI-generated, and verifiable therapeutic assets for you to fund and govern. We are the engine for the future of decentralized biotech.

5.0 A New Economic Engine: DeSci & Verification

We're not just building better therapeutics—we're creating an entirely new funding and verification paradigm that transforms how biotech innovation is financed and validated globally.

Traditional Funding Timeline

18-24 months

DeSci Funding Timeline

2-4 weeks

IP Liquidity Increase

10,000x

Global Investor Access

24/7

Step 1: IP-NFT Creation

We tokenize our therapeutic designs as IP-NFTs, creating liquid, tradeable intellectual property assets backed by real scientific value.

Step 2: Bio-DAO Partnerships

We partner with decentralized autonomous organizations focused on specific disease areas, leveraging their community and capital.

Step 3: Verification Layer

Our AI-powered verification system ensures the integrity and reproducibility of all research outputs, creating trust in the ecosystem.

Step 4: Global Liquidity

We create the world's first liquid market for biotech IP, enabling real-time price discovery and efficient capital allocation.

The DeSci Advantage

Why traditional biotech funding is broken and how we fix it

Traditional Problems:
  • 18-24 month funding cycles
  • Illiquid IP assets
  • Limited investor access
  • Opaque research processes
CrisPRO Solutions:
  • 2-4 week tokenized funding
  • 24/7 liquid IP markets
  • Global investor participation
  • AI-verified research integrity